HomeINDV • NASDAQ
Indivior PLC
add
$11.07
0.36%
After Hours:(0.00%)0.00
$11.07
Closed: May 15, 4:02:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 266.00M | -6.34% |
Operating expense | 154.00M | -9.94% |
Net income | 47.00M | -22.95% |
Net profit margin | 17.67 | -17.74% |
Earnings per share | 0.41 | 10.81% |
EBITDA | 73.00M | -8.75% |
Effective tax rate | 18.97% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 373.00M | 13.03% |
Total assets | 1.38B | -5.37% |
Total liabilities | 1.66B | 15.04% |
Total equity | -285.00M | — |
Shares outstanding | 124.77M | — |
Price to book | -4.84 | — |
Return on assets | 11.97% | — |
Return on capital | 133.86% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 47.00M | -22.95% |
Cash from operations | 75.00M | 302.70% |
Cash from investing | -5.00M | -120.00% |
Cash from financing | -17.00M | 69.64% |
Net change in cash | 53.00M | 177.94% |
Free cash flow | 98.00M | 1,220.00% |
Previous close
$11.03
Day range
$10.63 - $11.11
Year range
$7.33 - $18.59
Market cap
1.03B GBP
Avg Volume
949.49K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
About
Indivior is a specialty pharmaceuticals business. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, the company has been fined for false marketing claims about the safety of its drug, Suboxone. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
Founded
Sep 26, 2014
Website
Employees
1,041
